Literature DB >> 11964703

Physiopathology and treatment of severe drug eruptions.

N Bachot1, J C Roujeau.   

Abstract

This review will focus on recent advances concerning the most severe cutaneous drug reactions: the Stevens-Johnson syndrome, toxic epidermal necrolysis, and drug reactions with eosinophilia and systemic symptoms. The most significant progress concerned the demonstration that drugs more often than reactive metabolites are immunogenic and induced several kinds of responses. These findings provided the rationale for using new therapeutic approaches, which will be discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11964703     DOI: 10.1097/01.all.0000011029.46401.66

Source DB:  PubMed          Journal:  Curr Opin Allergy Clin Immunol        ISSN: 1473-6322


  5 in total

1.  Colonic involvement in Stevens-Johnson syndrome.

Authors:  N Powell; J M Munro; D Rowbotham
Journal:  Postgrad Med J       Date:  2006-06       Impact factor: 2.401

2.  Phenobarbital-induced bullous lesions in a non-comatose patient.

Authors:  Michael Keng; Maritza Lagos; Michael R Liepman; Kimberly Trever
Journal:  Psychiatry (Edgmont)       Date:  2006-12

Review 3.  Drug reactions with eosinophilia and systemic symptoms.

Authors:  B Scrace; A Fityan; C Bigham
Journal:  BJA Educ       Date:  2020-01-08

4.  New insights in toxic epidermal necrolysis (Lyell's syndrome): clinical considerations, pathobiology and targeted treatments revisited.

Authors:  Philippe Paquet; Gérald E Piérard
Journal:  Drug Saf       Date:  2010-03-01       Impact factor: 5.606

5.  A New-Onset Rash in the Setting of Rifaximin Treatment for Hepatic Encephalopathy.

Authors:  Cassandra D L Fritz; Corlan Adebajo; Andrew Aronsohn; Donald M Jensen
Journal:  ACG Case Rep J       Date:  2014-10-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.